Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2025-12-24 @ 3:15 PM
NCT ID: NCT01740492
Eligibility Criteria: Inclusion Criteria: * English speaking * Adults age 18-65 * Able to understand and give informed consent * Comfortable with the experimental protocol as outlined to them by the research team * Severe pain, pain score of at least 50/100 on Visual Analogue Scale (VAS) or 5/10 numerical ratings score * Acute pain, pain duration \< 7days * Deemed by treating ED attending physician to require IV opioid analgesia * ASA (American Society of Anesthesiologists) class I or II Exclusion Criteria: * Previously enrolled in the study * Neurologic, respiratory, or hemodynamic compromise * GCS (Glasgow Coma Scale) \<15 * Pox \<94%, RR \<10, or RR \>22 * SBP \<90, SBP\>180, or DBP \>110 * Discretion of treating physician * Pregnancy or breastfeeding * Known or suspected allergy to ketamine or morphine * Ketamine within 24 hours of presentation (prescription or illicit drugs) * Conscious sedation in ED (per treating physician), includes ketamine (for non-study purposes) * Known Renal (Cr\>2.0) or Liver Failure * Unstable psychiatric disease (as per treating physician) * History of stroke * History of cardiac disease * Prior myocardial infarction; Angina (Stable or Unstable) * Cardiac stents or bypass surgery
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT01740492
Study Brief:
Protocol Section: NCT01740492